Skip to main content
. Author manuscript; available in PMC: 2017 Jan 15.
Published in final edited form as: Cancer Res. 2016 Jan 7;76(2):370–376. doi: 10.1158/0008-5472.CAN-15-0547

Figure 1.

Figure 1

P53 alteration in BCC tumors as a function of increasing B haplotype blocks. The prevalence of p53 alteration (mutation or abnormal IHC) was calculated among individuals with varying numbers of KIR B haplotype blocks (summed across centromeric and telomeric blocks of the KIR locus). Those with p53 alterations were four times more likely to have KIR B then those with normal p53 (p<0.004); there was no evidence of a gene-dosage effect.